Dr. Jon LaPook discusses the controversy surrounding peptide sales, explaining why Health Secretary Robert F. Kennedy Jr.’s actions to potentially expand access to these unapproved drugs may be problematic. Peptides are being marketed for wellness purposes despite a lack of evidence proving their safety and effectiveness.
Dr. Jon LaPook explains why peptide sales are controversial (this article)3 articles from CBS News on this story